|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27,400 KRW | -2.84% |
|
-3.01% | +8.09% |
| 2023 | InBody Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
| 2022 | InBody Releases BPBIO 220 and BPBIO 250 | CI |
InBody Co.,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was KRW 2,695.71 million compared to KRW 2,072.07 million a year ago. Net income was KRW 10,348.17 million compared to KRW 10,051.53 million a year ago.
Basic earnings per share from continuing operations was KRW 794 compared to KRW 772 a year ago. Basic earnings per share was KRW 794 compared to KRW 772 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +8.09% | 262M | |
| +12.83% | 227B | |
| +13.90% | 192B | |
| +18.07% | 136B | |
| +28.60% | 108B | |
| +1.67% | 64.07B | |
| +18.08% | 52.1B | |
| +7.04% | 51.87B | |
| +10.85% | 44.33B | |
| +5.76% | 36.75B |
INBODY CO.,LTD 
